Hiroshi Ito

Dr. Hiroshi Ito


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
PDF file
CHChiharu Hidaka
Chiharu Hidaka
KSKosuke Soda
Kosuke Soda
TIToshihiro Ito
Toshihiro Ito
HIHiroshi Ito
Hiroshi Ito
Although verogenic Newcastle disease viruses (NDVs) generally cause subclinical infection in waterfowls such as ducks, NDVs with high virulence in waterfowl have been sporadically reported. We previously reported that the NDV d5a20b strain, which is obtained by serial passaging of the velogenic 9a5b strain in domestic ducks, showed increased virulence in ducks (Hidaka et al., 2021). The d5a20b strain had 11 amino acid substitutions in its P/V, M, F, HN, and L proteins as compared to 9a5b. In the present study, we generated a series of recombinant (r) NDVs with these amino acid substitutions to identify the molecular basis of virulence of NDV in ducks, and evaluated their influences on virulence and in vitro viral properties. Each of the single amino acid substitutions in either the F protein I142M or the M protein Q44R contributed to the enhancement of intracerebral and intranasal pathogenicity in domestic ducks. The cell-cell fusion activity of the virus with F I142M was five times higher than that of the parental r9a5b. The virus with M Q44R rapidly replicated in duck embryo fibroblasts. Additionally, the rM+F+HN strain, which has the same amino acid sequences as d5a20b in M, F, and HN proteins, showed the highest level of virulence and replication efficiency among the generated recombinant viruses, nearly comparable to rd5a20b. These results suggest that multiple factors are involved in the high growth ability of NDV in duck cells, leading to increased virulence in vivo.

21 September 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
NINorikazu Isoda
Norikazu Isoda
LHLim Yik Hew
Lim Yik Hew
KNKazuki Nishikawa
Kazuki Nishikawa
FTFumihito Takaya
Fumihito Takaya
YSYo Shimazu
Yo Shimazu
YSYoshihiro Sakoda
Yoshihiro Sakoda
Genetic and antigenic analyses were performed on highly pathogenic avian influenza viruses (HPAIVs) isolated in Hokkaido, northern Japan, during the winter of 2024–2025. Ninety-eight HPAIVs were isolated from feces of waterfowl, tracheal swabs from dead wild birds, or lung homogenates from dead chickens. Phylogenetic analysis of the hemagglutinin (HA) gene from 47 representative isolates revealed that all sequences belonged to the G2d subgroup of clade 2.3.4.4b H5HA, which has been the dominant lineage in Hokkaido since the winter of 2021–2022. These isolates were further divided into three major groups within the subgroup. The HPAIVs isolated in the Republic of Korea, China, and North America were genetically closely related to the Hokkaido isolates, whereas no HPAIVs genetically related to European strains or those detected in North American cattle were identified. Furthermore, HPAIVs isolated from seabirds were genetically closely related to those found in dead marine mammals along the eastern coast of Hokkaido in the spring of 2025. No apparent antigenic differences were observed between the HPAIVs isolated in this study and those from previous seasons. These findings highlight the wide distribution of HPAIVs in Hokkaido, particularly from Asian and North American lineages, and underscore the importance of continuous surveillance.

1 February 2026 in Research Square
Verified
Preprint
Open access
PDF file
JFJun Fujii
Jun Fujii
SSSatoshi Shibata
Satoshi Shibata
HIHiroshi Ito
Hiroshi Ito
TIToshihiro Ito
Toshihiro Ito
SWShohei Wakao
Shohei Wakao
MDMari Dezawa
Mari Dezawa
Background Long COVID, including symptoms such as asthma, allergies, musculoskeletal pain, diabetes, insomnia, headaches, chronic fatigue, and frailty persisting for at least 2 months following acute SARS-CoV-2 infection, is a global health concern with no established treatments. While some studies demonstrated efficacy using mesenchymal stem cells (MSCs), outcomes have been inconsistent. Methods In the present study, we evaluated a small, distinct subset of SSEA-3(+) MSCs, known as multilineage-differentiating stress-enduring (Muse) cells, in a preclinical model of SARS-CoV-2 infection. Here, in a Syrian hamster model of SARS-CoV-2 infection, Syrian hamsters were intranasally inoculated with SARS-CoV-2 on day 0, and then on day 2, the hamsters were intravenously administered Muse cells, non-Muse cells, or vehicle (saline). On day 8, the hamsters were sacrificed, and the lungs and olfactory bulb (OB) were removed from the body to perform the experiments including inflammatory response, apoptosis, fibrosis (lung only). At the same time, total RNA was extracted from the lung and OB for RNA-seq and IPA analysis. Results We demonstrated that intravenous treatment with human-bone marrow-derived Muse cells more effectively reduced inflammation, fibrosis, and apoptosis than non-Muse-MSCs while preserving oxygen saturation, body weight, lung and olfactory bulb structure, and alveolar air space. RNA sequencing identified 64 differentially expressed genes associated with Muse cell-mediated tissue protection, with distinct profiles in olfactory bulb and lung tissues. Although this study does not directly assess long COVID, the marked suppression of severe COVID-associated pathology suggests that Muse cell treatment holds promise as a potential therapeutic approach for long COVID. Conclusions Our findings demonstrated that Muse cells suppressed the expression of inflammatory, apoptosis, fibrosis mediators that may exacerbate severe COVID-19 pathology as ARDS. Some reports suggest that SARS-CoV-2 infection in the olfactory bulb provides a route for SARS-CoV-2 viral invasion of the brain, leading to neurologic symptoms of long COVID. Therefore, we propose that Muse cells could ameliorate both pulmonary and neurologic components of long COVID by suppressing key inflammatory and fibrotic pathways. Because Finally, these findings suggest that Muse cells may be a promising therapeutic approach for mitigating the symptoms of severe COVID-19 infection and preventing long COVID.